New Cdc2 Tyr 4 Phosphorylation by DsRNA-activated Protein Kinase Triggers Cdc2 Polyubiquitination and G2 Arrest Under Genotoxic Stresses
Overview
Affiliations
Cell division cycle 2 (Cdc2) protein is an essential subunit of M-phase kinase (MPK), which has a key role in G2/M transition. Even though the control of MPK activity has been well established with regard to the phosphorylation of Cdc2 at Thr 14 and/or Tyr 15 and Thr 161, little is known about the proteolytic control of Cdc2. In this study, we observed that Cdc2 was downregulated under genotoxic stresses and that double-stranded RNA-activated protein kinase (PKR) was involved in the process. The PKR-mediated Tyr4 phosphorylation triggered Cdc2 ubiquitination. Phospho-mimic mutations at the Tyr 4 residue (Y4D or Y4E) caused significant ubiquitination of Cdc2 even in the absence of PKR. Our findings demonstrate that (i) PKR, Ser/Thr kinase, phosphorylates its new substrate Cdc2 at the Tyr 4 residue, (ii) PKR-mediated Tyr 4-phosphorylation facilitates Cdc2 ubiquitination and proteosomal degradation, (iii) unphosphorylated Tyr 4 prevents Cdc2 ubiquitination, and (iv) downstream from p53, PKR has a crucial role in G2 arrest and triggers Cdc2 downregulation under genotoxic conditions.
Bu H, Pei C, Ouyang M, Chen Y, Yu L, Huang X Cancer Gene Ther. 2024; 32(1):61-70.
PMID: 39562696 DOI: 10.1038/s41417-024-00855-8.
Targeting CDK1 in cancer: mechanisms and implications.
Wang Q, Bode A, Zhang T NPJ Precis Oncol. 2023; 7(1):58.
PMID: 37311884 PMC: 10264400. DOI: 10.1038/s41698-023-00407-7.
Kinases on Double Duty: A Review of UniProtKB Annotated Bifunctionality within the Kinome.
Rangwala A, Mingione V, Georghiou G, Seeliger M Biomolecules. 2022; 12(5).
PMID: 35625613 PMC: 9138534. DOI: 10.3390/biom12050685.
GPS 5.0: An Update on the Prediction of Kinase-specific Phosphorylation Sites in Proteins.
Wang C, Xu H, Lin S, Deng W, Zhou J, Zhang Y Genomics Proteomics Bioinformatics. 2020; 18(1):72-80.
PMID: 32200042 PMC: 7393560. DOI: 10.1016/j.gpb.2020.01.001.
Gal-Ben-Ari S, Barrera I, Ehrlich M, Rosenblum K Front Mol Neurosci. 2019; 11:480.
PMID: 30686999 PMC: 6333748. DOI: 10.3389/fnmol.2018.00480.